Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Cardene In 4.8% Dextrose In Plastic Container

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

35 API Suppliers, 14 USDMF, 1 CEP/COS, 1 JDMF, 2 EU WC, 2 KDMF, 7 NDC API, 24 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

9 Drugs in Development

9 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

80 FDF Dossiers, 51 FDA Orange Book, 14 Europe, 1 South Africa, 14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INTRAVENOUS - 20MG/200ML (0.1MG/ML), INJECTABLE;INJECTION - 25MG/10ML (2.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INTRAVENOUS - 40MG/200ML (0.2MG/ML)

RELATED EXCIPIENT COMPANIES

2 Evonik, 1 Rochem International Inc, 6 SPI Pharma, 8 DKSH, 4 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 2 Kirsch Pharma, 4 ACG Worldwide, 2 Actylis, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 1 CD Formulation, 3 Corel Pharma Chem, 2 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 5 Ideal Cures, 2 Ingredion Pharma Solutions, 3 Kerry, 1 Keval Exports, 3 Lonza Capsugel, 7 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 1 Qualicaps, 28 Roquette, 2 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 2 Silverline Chemicals, 2 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

40 Fillers, Diluents & Binders, 27 Coating Systems & Additives, 17 Thickeners and Stabilizers, 16 Direct Compression, 15 Taste Masking, 13 Film Formers & Plasticizers, 13 Controlled & Modified Release, 12 Lubricants & Glidants, 11 Co-Processed Excipients, 11 Granulation, 9 Chewable & Orodispersible Aids, 9 Parenteral, 8 Empty Capsules, 7 Disintegrants & Superdisintegrants, 5 Solubilizers, 4 Topical, 4 Emulsifying Agents, 3 Coloring Agents, 1 Soft Gelatin, 1 API Stability Enhancers, 1 Surfactant & Foaming Agents, 1 Rheology Modifiers

DIGITAL CONTENT

4 Data Compilation #PharmaFlow, 23 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 5 Regulatory FDF Prices

MARKET PLACE

19 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

22 US Patents, 2 US Exclusivities

REF. STANDARDS & IMPURITIES

1 EDQM, 2 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
29/11/2025	Daito Pharmaceutical	Japan	Daito Co., Ltd.	218MF11014	Japanese Pharmacopoeia Nicardipine Hydrochloride (for m...	2006-12-18	2006-12-18	326 Yokamachi, Toyama City, Toyama Prefecture
29/11/2025	Sanyo Chemical Research Institute Co., Ltd.	Gabon	Sanyo Chemical Research Institute Co., Ltd.	219MF10079	Nicardipine hydrochloride	2007-03-14	2007-03-14	148-1 Tajii, Mihara-ku, Sakai City, Osaka Prefecture

Cardene In 4.8% Dextrose In Plastic Container

Cardene In 4.8% Dextrose In Plastic Container

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

35 API Suppliers

14 USDMF

1 CEP/COS

1 JDMF

2 EU WC

2 KDMF

7 NDC API

24 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

9 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

80 FDF Dossiers

51 FDA Orange Book

14 Europe

1 South Africa

14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INTRAVENOUS - 20MG/200ML (0.1MG/ML)

INJECTABLE;INJECTION - 25MG/10ML (2.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INTRAVENOUS - 40MG/200ML (0.2MG/ML)

RELATED EXCIPIENT COMPANIES

2 Evonik

1 Rochem International Inc

6 SPI Pharma

8 DKSH

4 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

2 Kirsch Pharma

4 ACG Worldwide

2 Actylis

1 Alcedo Pharmachem

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

11 BASF

1 CD Formulation

3 Corel Pharma Chem

2 DFE Pharma

1 Finar

6 Gangwal Chemicals

5 Ideal Cures

2 Ingredion Pharma Solutions

3 Kerry

1 Keval Exports

3 Lonza Capsugel

7 Microlex e.U

2 Nitika Pharmaceutical Specialities

1 Pharmatrans-Sanaq

3 Pluviaendo

2 Prachin Chemical

1 Qualicaps

28 Roquette

2 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

8 Sigachi Industries

2 Silverline Chemicals

2 Valens Pharmachem

2 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

40 Fillers, Diluents & Binders

27 Coating Systems & Additives

17 Thickeners and Stabilizers

16 Direct Compression

15 Taste Masking

13 Film Formers & Plasticizers

13 Controlled & Modified Release

12 Lubricants & Glidants

11 Co-Processed Excipients

11 Granulation

9 Chewable & Orodispersible Aids

INJECTABLE;INJECTION - 25MG/10ML (2.5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons